502
Views
12
CrossRef citations to date
0
Altmetric
Review

Polyarticular juvenile idiopathic arthritis – epidemiology and management approaches

, &
Pages 379-393 | Published online: 24 Oct 2014

References

  • PettyRESouthwoodTRMannersPInternational League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001J Rheumatol200431239039214760812
  • RavelliAMartiniAJuvenile idiopathic arthritisLancet2007369956376777817336654
  • RingoldSSeidelKDKoepsellTDWallaceCAInactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associationsRheumatology (Oxford)200948897297719535609
  • European League Against RheumatismEULAR Bulletin No 4: Nomenclature and Classification of Arthritis in ChildrenBaselNational Zeitung AG1977
  • CassidyJTLevinsonJEBassJCA study of classification criteria for a diagnosis of juvenile rheumatoid arthritisArthritis Rheum19862922742813485433
  • MartiniAJIA in 2011: new takes on categorization and treatmentNat Rev Rheumatol201282676822231236
  • RavelliAFeliciEMagni-ManzoniSPatients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint diseaseArthritis Rheum200552382683215751057
  • RavelliAVarnierGCOliveiraSAntinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritisArthritis Rheum201163126727520936630
  • SailerMCabralDPettyREMallesonPNRheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritisJ Rheumatol1997245865889058670
  • BrunnerJSitzmannFCThe diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritisClin Exp Rheumatol200624444945116956438
  • TeboAEJaskowskiTDavisKWProfiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritisPediatr Rheumatol Online J20121012922931121
  • GreenwaldAGZakerzadehALaxerRMLater-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group?Clin Exp Rheumatol201331464565223622111
  • RingoldSWeissPFColbertRAChildhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritisArthritis Care Res (Hoboken) Epub12102013
  • FujikawaSOkuniMA nationwide surveillance study of rheumatic diseases among Japanese childrenActa Paediatr Jpn19973922422449141265
  • HuangJLYaoTCSeeLCPrevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in TaiwanClin Exp Rheumatol200422677678015638056
  • AdibNHyrichKThorntonJAssociation between duration of symptoms and severity of disease at first presentation to pediatric rheumatology: results from the Childhood Arthritis Prospective StudyRheumatology (Oxford)200847799199518417527
  • SaurenmannRKRoseJBTyrrellPEpidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factorArthritis Rheum20075661974198417530723
  • AkhterEBilalSKianiAHaqueUPrevalence of arthritis in India and Pakistan: a reviewRheumatol Int201131784985521331574
  • BerntsonLAndersson GareBFasthAIncidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteriaJ Rheumatol200330102275228214528529
  • Kaipiainen-SeppanenOSavolainenAChanges in the incidence of juvenile rheumatoid arthritis in FinlandRheumatology (Oxford)200140892893211511763
  • PruunsildCUiboKLiivamagiHTarrasteSTalvikTPelkonenPIncidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based studyScand J Rheumatol200736171317454929
  • MannersPJDiepeveenDAPrevalence of juvenile chronic arthritis in a population of 12-year-old children in urban AustraliaPediatrics199698184908668417
  • Von KoskullSTruckenbrodtHHolleRHormannAIncidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective studyAnn Rheum Dis2001601094094511557650
  • TownerSRMichetCJJrO’FallonWMNelsonAMThe epidemiology of juvenile arthritis in Rochester, Minnesota 1960–1979Arthritis Rheum19832610120812136626278
  • ModestoCAntonJRodriguezBIncidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain)Scand J Rheumatol201039647247920858139
  • PetersonLSMasonTNelsonAMO’FallonWMGabrielSEJuvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993. Is the epidemiology changing?Arthritis Rheum1996398138513908702448
  • Solau-GervaisERobinCGambertCPrevalence and distribution of juvenile idiopathic arthritis in a region of Western FranceJoint Bone Spine2010771474920034832
  • MielantsHVeysEMMaertensMPrevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in BelgiumClin Exp Rheumatol19931155635678275595
  • DannerSSordetCTerzicJEpidemiology of juvenile idiopathic arthritis in Alsace, FranceJ Rheumatol20063371377138116821272
  • ArguedasOPorrasOFasthAJuvenile chronic arthritis in Costa Rica. A pilot referral studyClin Exp Rheumatol19951311191237774091
  • MerinoRDe InocencioJGarcia-ConsuegraJEvaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish childrenJ Rheumatol200128122731273611764225
  • PruunsildCUiboKLiivamagiHTarrasteSTalvikTPelkonenPPrevalence and short-term outcomes of juvenile idiopathic arthritis: a population-based study in EstoniaClin Exp Rheumatol200725464965317888227
  • FujikawaSOkuniMClinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in JapanActa Paediatr Jpn19973922452499141266
  • Krumrey-LangkammererMHafnerREvaluation of the ILAR criteria for juvenile idiopathic arthritisJ Rheumatol200128112544254711708431
  • KunjirVVenugopalanAChopraAProfile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort studyJ Rheumatol20103781756176220516021
  • Abou El-SoudAMEl-NajjarAREl-ShahawyEEPrevalence of juvenile idiopathic arthritis in Sharkia Governorate, Egypt: epidemiological studyRheumatol Int20133392315232223512174
  • OenKFastMPostlBEpidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975–92: cycles in incidenceJ Rheumatol19952247457507791175
  • GareBAFasthAEpidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population studyPediatrics19929069509581437440
  • YilmazMKendirliSGAltintasDUKarakocGBInalAKilicMJuvenile idiopathic arthritis profile in Turkish childrenPediatr Int200850215415818353049
  • WeakleyKEsserMScottCJuvenile idiopathic arthritis in two tertiary centers in the Western Cape, South AfricaPediatr Rheumatol Online J20121013523050608
  • KhuffashFAMajeedHALubaniMMNajdiKNGunawardanaSSBushnarqREpidemiology of juvenile chronic arthritis and other connective tissue diseases among children in KuwaitAnn Trop Paediatr19901032552591703741
  • ChipetaJNjobvuPWa-SomweSChintuCMcGillPEBucalaRClinical patterns of juvenile idiopathic arthritis in ZambiaPediatr Rheumatol Online J20131113324034206
  • HanovaPPavelkaKDostalCHolcatovaIPikhartHEpidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003Clin Exp Rheumatol200624549950717181917
  • AggarwalAMisraRJuvenile chronic arthritis in India: is it different from that seen in Western countries?Rheumatol Int199414253567529938
  • AdelowoOOUmarAJuvenile idiopathic arthritis among Nigerians: a case studyClin Rheumatol201029775776120195880
  • NielsenHEDorupJHerlinTLarsenKNielsenSPedersenFKEpidemiology of juvenile chronic arthritis: risk dependent on sibship, parental income, and housingJ Rheumatol19992671600160510405951
  • EllisJAPonsonbyALPezicACLARITY – ChiLdhood Arthritis Risk factor Identification sTudYPediatr Rheumatol Online J20121013723153063
  • Ehrmann FeldmanDBernatskySHoudeMThe incidence of juvenile rheumatoid arthritis in Quebec: a population data-based studyPediatr Rheumatol Online J200972019922673
  • BertilssonLAndersson-GareBFasthAPeterssonIFForsblad-D’eliaHDisease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 yearsJ Rheumatol201340571572423418376
  • FantiniFGerloniVGattinaraMCimazRArnoldiCLupiERemission in juvenile chronic arthritis: a cohort of 683 consecutive cases with a mean 10 year follow-upJ Rheumatol200330357958412610820
  • OenKMallesonPNCabralDARosenbergAMPettyRECheangMDisease course and outcome of juvenile rheumatoid arthritis in a multicenter cohortJ Rheumatol20022991989199912233897
  • VidqvistKLMalinMVarjolahti-LehtinenTKorpelaMMDisease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapiesRheumatology (Oxford)201352111999200323893666
  • FlatoBLienGSmerdelAPrognostic factors in juvenile rheumatoid arthritis: a case–control study revealing early predictors and outcome after 14.9 yearsJ Rheumatol200330238639312563700
  • BeukelmanTPatkarNMSaagKG2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic featuresArthritis Care Res (Hoboken)201163446548221452260
  • GilliamBEChauhanAKLowJMMooreTLMeasurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative studyClin Exp Rheumatol200826349249718578976
  • OmarAAbo-ElyounIHusseinHAnti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial)Joint Bone Spine2013801384322575064
  • RupertoNRavelliALevinsonJELong-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcomeJ Rheumatol19972459529589150088
  • Magni-ManzoniSRossiFPistorioAPrognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritisArthritis Rheum200348123509351714674002
  • OenKMallesonPNCabralDAEarly predictors of long-term outcomes in patients with juvenile rheumatoid arthritis: subset-specific correlationsJ Rheumatol200330358559312610821
  • PackhamJCHallMALong-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcomeRheumatology (Oxford)200241121428143512468825
  • PackhamJCHallMAPimmTJLong-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and painRheumatology (Oxford)200241121444144912468828
  • PackhamJCHallMALong-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employmentRheumatology (Oxford)200241121436143912468826
  • ThomasESymmonsDPMBrewsterDHBlackRJMacfarlaneGJNational study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year follow-up studyJ Rheumatol200330595896512734889
  • HinksACobbJMarionMCDense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritisNat Genet201345666466923603761
  • PhelanJDThompsonSDGlassDNSusceptibility to JRA/JIA: complementing general autoimmune and arthritis traitsGenes Immun20067111016435022
  • MoroldoMBTagueBLShearESGlassDNGianniniEHJuvenile rheumatoid arthritis in affected sibpairsArthritis Rheum19974011196219669365084
  • PrahaladSZeftASPimentelRQuantification of the familial contribution to juvenile idiopathic arthritisArthritis Rheum20106282525252920506132
  • PrahaladSGlassDNA comprehensive review of the genetics of juvenile idiopathic arthritisPediatr Rheumatol Online J200861118644131
  • MurrayKJMoroldoMBDonnellyPAge-specific effects of juvenile rheumatoid arthritis-associated HLA allelesArthritis Rheum19994291843185310513798
  • GormanJDCriswellLAThe shared epitope and severity of rheumatoid arthritisRheum Dis Clin North Am2002281597811840698
  • Fernandez-VinaMFinkCWStastnyPHLA associations in juvenile arthritisClin Exp Rheumatol19941222052148039292
  • ThomsonWBarrettJHDonnRJuvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patientsRheumatology (Oxford)200241101183118912364641
  • HallenbachJAThompsonSDBugawanTLJuvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effectsArthritis Rheum20106261781179120191588
  • PrahaladSRyanMHShearESThompsonSDGianniniEHGlassDNJuvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairsArthritis Rheum200043102335233811037894
  • HinksABartonAJohnSAssociation between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity geneArthritis Rheum20055261694169915934099
  • VangTCongiaMMacisMDAutoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variantNat Genet200537121317131916273109
  • PrahaladSHansenSWhitingAVariants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritisArthritis Rheum20096072124213019565500
  • ZhaoYLiuXLiuXAssociation of STAT4 gene polymorphism with increased susceptibility of rheumatoid arthritis in a northern Chinese Han subpopulationRheum Dis2013162178184
  • AlbersHMKurreemanFAHouwing-DuistermaatJJThe TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritisAnn Rheum Dis200867111578158018593758
  • SchmelingHWagnerUPetersonAHorneffGTumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritisClin Exp Rheumatol200624110310816539828
  • HinksACobbJSudmanMInvestigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlapAnn Rheum Dis20127171117112122294642
  • ThompsonSDSudmanMRamosPSThe susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1Arthritis Rheum201062113265327620722033
  • M’RabetLVosAPBoehmGGarssenJBreast-feeding and its role in early development of the immune system in infants: consequences for health later in lifeJ Nutr200813891782S1790S18716187
  • MasonTRabinovichCEFredricksonDDBreast-feeding and the development of juvenile rheumatoid arthritisJ Rheumatol1995226116611707674248
  • RosenbergAMEvaluation of associations between breast feeding and subsequent development of juvenile rheumatoid arthritisJ Rheumatol1996236108010828782143
  • YoungKAParrishLAZerbeGOPerinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy pediatric populationAnn Rheum Dis200766217918317242018
  • JacobssonLTJacobssonMEAsklingJKnowlerWCPerinatal characteristics and risk of rheumatoid arthritisBMJ200332673981068106912750209
  • SugiyamaDNishimuraKTamakiKImpact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studiesAnn Rheum Dis2010691708119174392
  • WilsonKGoldsmithCHDoes smoking cause rheumatoid arthritis?J Rheumatol1999261139918232
  • GeorgeJLevyYSchoenfeldYSmoking and immunity: an additional player in the mosaic of autoimmunityScand J Immunol1997451169010493
  • JaakkolaJJGisslerMMaternal smoking in pregnancy as a determinant of rheumatoid arthritis and other inflammatory polyarthropathies during the first 7 years of lifeInt J Epidemiol200534366467115649961
  • CarlensCJacobssonLTBrandtLCnattingiusSStephanssonOAsklingJPerinatal characteristics, early life infections, and later risk of rheumatoid arthritis and juvenile idiopathic arthritisAnn Rheum Dis20096871159116418957482
  • HeiselJSLife changes as etiologic factors in juvenile rheumatoid arthritisJ Psychosom Res19721664114204666658
  • MeyerowitzSJacoxRFHessDWMonozygotic twins discordant for rheumatoid arthritis: a genetic, clinical, and psychological study of eight setsArthritis Rheum19681111215640607
  • HenochMJBatsonJWBaumJPsychosocial factors in juvenile rheumatoid arthritisArthritis Rheum1978212229233637889
  • NeufeldKMKarunanayakeCPMaenzLYRosenbergAMStressful life events antedating chronic childhood arthritisJ Rheumatol201340101756176523950190
  • VandvikIHHoyeraalHMFagertunHChronic family difficulties and stressful life events in recent onset juvenile arthritisJ Rheumatol1989168108810922585405
  • SlopenNKubzanskyLDMcLaughlinKAKoenenKCChildhood adversity and inflammatory processes in youth: a prospective studyPsychoneuroendocrinology201338218820022727478
  • Roupe van der VoortCHeijnenCJWulffraatNKuisWKavelaarsAStress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for α1-adrenergic receptorsJ Neuroimmunol20001101–222322911024553
  • FranssilaRHedmanKInfection and musculoskeletal conditions: viral causes of arthritisBest Pract Res Clin Rheumatol20062061139115717127201
  • KivitySArangoMTEhrenfeldMInfection and autoimmunity in Sjogren’s syndrome: a clinical study and comprehensive reviewJ Autoimmun201451172224637076
  • ShoenfeldYZandman-GoddardGStojanovichLThe mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases – 2008Isr Med Assoc J200810181218300563
  • FreimanisGHooleyPEjtehadiHDA role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesisClin Exp Immunol2010160334034720345981
  • PritchardMHMatthewsNMunroJAntibodies to influenza A in a cluster of children with juvenile chronic arthritisBr J Rheumatol19882731761803378122
  • ChantlerJKTingleAJPettyREPersistent rubella virus infection associated with chronic arthritis in childrenN Engl J Med198531318111711234047116
  • GonzalezBLarrangaCLeonOParvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritisJ Rheumatol20073461336134017477467
  • AghighiYGilani ShMRazaviMZamaniADaneshjooKJuvenile rheumatoid arthritis in children with Ebstein Barr virus infectionPak J Biol Sci200710203638364319093474
  • HokynarKBrunsteinJSoderlund-VenermoMIntegrity and full coding sequence of B19 virus DNA persisting in human synovial tissueJ Gen Virol200081Pt 41017102510725428
  • ZulianFMartiniGGobberDPlebaniMZacchelloFMannersPTriamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trialRheumatology (Oxford)200443101288129115252213
  • WallaceCAGianniniEHSpaldingSJTrial of early aggressive therapy in polyarticular juvenile idiopathic arthritisArthritis Rheum20126462012202122183975
  • GianniniERupertoNRavelliALovellDJFelsonDTMartiniAPreliminary definition of improvement in juvenile arthritisArthritis Rheum1997407120212099214419
  • IlowiteNTLaxerRMPharmacology and drug therapyCassidyJTPettyRELaxerRMLindsleyCBTextbook of Pediatric Rheumatology6th edPhiladelphia, PASaunders Elsevier201171126
  • GianniniEHBrewerEJKuzminaNMethotrexate in resistant juvenile rheumatoid arthritis: results of the USA–USSR double-blind, placebo-controlled trialN Engl J Med199232616104310491549149
  • WooPSouthwoodTRPrieurAMRandomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritisArthritis Rheum20004381849185710943876
  • KleinAKaulIFoeldvariIGanserGUrbanAHorneffGEfficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate RegistryArthritis Care Res (Hoboken)20126491349135622649024
  • SilvermanEMouyRSpiegelLLeflunomide or methotrexate for juvenile rheumatoid arthritisN Engl J Med2005352161655166615843668
  • SilvermanESpiegelLHawkinsDLong-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritisArthritis Rheum200552255456215693001
  • Van RossumMAFiselierTJFranssenMJSulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled multicenter studyArthritis Rheum19984158088169588731
  • SavolainenHAKautiainenHIsomakiHAhoKVerronenPAzathioprine in patients with juvenile chronic arthritis: a long-term follow-up studyJ Rheumatol19972412244424509415656
  • RupertoNRavelliACastellECyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO Phase IV post marketing surveillance studyClin Exp Rheumatol200624559960517181934
  • BrewerEJGianniniEHKuzminaNAlekseevLPenicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the USA–USSR double-blind placebo-controlled trialN Engl J Med198631420126912763517643
  • TanakaHTsugawaKSuzukiKTreatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimusEur J Pediatr2007166101053105517187256
  • LehmanTJSchechterSJSundelRPOliveiraSKHuttenlocherAOnelKBThalidomide for severe systemic onset juvenile rheumatoid arthritis: a multicenter studyJ Pediatr2004145685685715580219
  • O’DellJRMikulsTRTaylorTHTherapies for active rheumatoid arthritis after methotrexate failureN Engl J Med2013369430731823755969
  • LovellDJGianniniEHReiffAEtanercept in children with polyarticular juvenile rheumatoid arthritisN Engl J Med20003421176376910717011
  • TynjalaPVahasaloPTarkiainenMAggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicenter randomized open-label clinical trialAnn Rheum Dis20117091605161221623000
  • OttenMHPrinceFHArmbrustWFactors associated with treatment response to etanercept in juvenile idiopathic arthritisJAMA2011306212340234722056397
  • RupertoNLovellDJCutticaRA randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritisArthritis Rheum20075693096310617763439
  • LovellDJRupertoNGoodmanSAdalimumab with or without methotrexate in juvenile rheumatoid arthritisN Engl J Med2008359881082018716298
  • RupertoNLovellDJQuartierPAbatacept in children with juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled withdrawal trialLancet2008372963638339118632147
  • RupertoNLovellDJLiTAbatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritisArthritis Care Res (Hoboken)201062111542155120597110
  • YokotaSImagawaTMoriMEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal Phase III trialLancet20083719617998100618358927
  • De BenedettiFBrunnerHIRupertoNRandomized trial of tocilizumab in systemic juvenile idiopathic arthritisN Engl J Med2012367252385239523252525
  • BrunnerHRupertoNZuberZEfficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: data from a Phase III trial [abstract]Arthritis Rheum201264Suppl 10S682
  • BrunnerHIRupertoNZuberZEfficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: 2-year data from CHERISH [abstract]Arthritis Rheumatol201466Suppl 11S5S6
  • AlexeevaEIValievaSIBzarovaTMEfficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritisClin Rheumatol20113091163117221384257
  • GianniniEHLovellDJSilvermanEDSundelRPTagueBLRupertoNIntravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a Phase I/II studyJ Rheumatol19962359199248724309
  • CohenSHurdECushJTreatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a 24-week multicenter, randomized, double-blind, placebo-controlled trialArthritis Rheum200246361462411920396
  • IlowiteNPorrasOReiffAAnakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter studyClin Rheumatol200928212913718766426
  • QuartierPAllantazFCimazRA multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Ann Rheum Dis201170574775421173013
  • NigrovicPAMannionMPrinceFHAnakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of 46 patients from an international multicenter studyArthritis Rheum201163254555521280009
  • RupertoNBrunnerHIQuartierPTwo randomized trials of canakinumab in systemic juvenile idiopathic arthritisN Engl J Med2012367252396240623252526
  • LovellDJGianniniEHKimuraYLong-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritisArthritis Rheum20136592486249623754188
  • RingoldSWeissPFBeukelmanT2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medicationsArthritis Rheum201365102499251224092554
  • Ruiz GarciaVJobanputraPBurlsACertolizumab pegol (CDP870) for rheumatoid arthritis in adults [review]Cochrane Database Syst Rev20112CD00764921328299
  • SinghJANoorbaloochiSSinghGGolimumab for rheumatoid arthritis: a systematic reviewJ Rheumatol20103761096110420436075
  • UCB Biosciences GmbHPediatric arthritis study of certolizumab pegol (PASCAL) Available from: http://clinicaltrials.gov/ct2/show/NCT01550003. NLM identifier: NCT01550003Accessed June 27, 2014
  • BrunnerHRupertoNTzaribachevNA multi-center, double-blind, randomized-withdrawal trial of subcutaneous golimumab in pediatric patients with active polyarticular course juvenile idiopathic arthritis despite methotrexate therapy: week 48 results [abstract]Arthritis Rheumatol201466Suppl 11S191S192
  • TzaribachevNTzaribachevCMehrwaldMKoosBGO-Kids imaging substudy: MRI treatment response to 30 mg/m2 4-weekly subcutaneous injections of golimumab in children with polyarticular JIA – preliminary results of the open label portion [abstract]Arthritis Rheum201365Suppl 10S118
  • FleischmannRKremerJCushJPlacebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritisN Engl J Med2012367649550722873530
  • PfizerLong-term safety study of CP-690,550 in patients with juvenile idiopathic arthritis Available from: http://clinicaltrials.gov/ct2/show/NCT01500551. NLM identifier: NCT01500551Accessed June 27, 2014
  • GalienRVayssiereBde VosSAnalysis of the JAK1 selectivity of GLPG0634 and its main metabolite in different species, healthy volunteers, and rheumatoid arthritis patients [abstract]Arthritis Rheum201365Suppl 10S209S210
  • GalapagosNVLong-term follow-up study of GLPG0634 in active rheumatoid arthritis patients (DARWIN3) Available from: http/:clinicaltrials.gov/show/NCT02065700. NLM identifier: NCT02065700Accessed June 27, 2014
  • VojinovicJDamjanovND’UrzoCSafety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritisArthritis Rheum20116351452145821538322
  • VojinovicJDamjanovNHDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritisMol Med2011175–639740321308151
  • TakPPBalanescuATseluykoVChemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomized, placebo controlled clinical trialAnn Rheum Dis201372333734422589376
  • DawesPDimicAGenoveseMCOskira-2: a Phase III, multicenter, randomized, double-blind, placebo-controlled parallel-group study of two dosing regimens of fostamatinib in rheumatoid arthritis patients with an inadequate response to disease-modifying antirheumatic drugs [abstract]Arthritis Rheum201365Suppl 10S198S199
  • GenoveseMvan der HeijdeDKeystoneEOskira-3: a Phase III, multicenter, randomized, double-blind, placebo-controlled parallel-group study of two dosing regimens of fostamatinib in rheumatoid arthritis patients with an inadequate response to a tumor necrosis factor-α antagonist [abstract]Arthritis Rheum201365Suppl 10S199S200
  • GenoveseMCCarlierHEricksonJBraunDBanerjeeSResults of 64 weeks of treatment with an anti-IL-17 antibody, ixekizumab, in patients with rheumatoid arthritis in a Phase II study [abstract]Arthritis Rheum201365Suppl 10S188
  • ConsolaroARupertoNFilocamoGSeeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: introduction of the EPOCA studyPediatr Rheumatol Online J20121013923164467
  • OtaSCronRQSchanbergLEResearch priorities in pediatric rheumatology: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensusPediatric Rheumatol Online J200865